GB0406749D0 - Novel adjuvant - Google Patents

Novel adjuvant

Info

Publication number
GB0406749D0
GB0406749D0 GBGB0406749.2A GB0406749A GB0406749D0 GB 0406749 D0 GB0406749 D0 GB 0406749D0 GB 0406749 A GB0406749 A GB 0406749A GB 0406749 D0 GB0406749 D0 GB 0406749D0
Authority
GB
United Kingdom
Prior art keywords
novel adjuvant
adjuvant
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0406749.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Cambridge University Technical Services Ltd CUTS
Original Assignee
Glaxo Group Ltd
Cambridge University Technical Services Ltd CUTS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Cambridge University Technical Services Ltd CUTS filed Critical Glaxo Group Ltd
Priority to GBGB0406749.2A priority Critical patent/GB0406749D0/en
Publication of GB0406749D0 publication Critical patent/GB0406749D0/en
Priority to PCT/EP2005/003248 priority patent/WO2005102394A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB0406749.2A 2004-03-25 2004-03-25 Novel adjuvant Ceased GB0406749D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0406749.2A GB0406749D0 (en) 2004-03-25 2004-03-25 Novel adjuvant
PCT/EP2005/003248 WO2005102394A1 (en) 2004-03-25 2005-03-23 Uric acid as adjuvant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0406749.2A GB0406749D0 (en) 2004-03-25 2004-03-25 Novel adjuvant

Publications (1)

Publication Number Publication Date
GB0406749D0 true GB0406749D0 (en) 2004-04-28

Family

ID=32188698

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0406749.2A Ceased GB0406749D0 (en) 2004-03-25 2004-03-25 Novel adjuvant

Country Status (2)

Country Link
GB (1) GB0406749D0 (en)
WO (1) WO2005102394A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014510721A (en) * 2011-02-15 2014-05-01 イミューン デザイン コーポレイション Methods for enhancing immunogen-specific immune responses with vector vaccines
MX2015005306A (en) * 2012-10-25 2015-07-17 Glaxosmithkline Biolog Sa Nicotinamide as adjuvant.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7807187B2 (en) * 2003-05-13 2010-10-05 The University Of Massachusetts Endogenous adjuvant molecules and uses thereof

Also Published As

Publication number Publication date
WO2005102394A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
ZA200609595B (en) Novel CIS-Imidazolines
IL179730A0 (en) Novel cis-imidazolines
TWI372750B (en) Novel hydroxy-6-heteroarylphenanthridines
GB0512751D0 (en) New adjuvant
ZA200610303B (en) Novel cis-imidazolines
GB0414026D0 (en) Novel uses
GB0507672D0 (en) Adjuvant
GB0406749D0 (en) Novel adjuvant
ZA200606635B (en) Novel isoamido-substituted hydroxy-6-phenylphenanthridines
GB0408865D0 (en) Novel benzoxazocines
GB0408863D0 (en) Novel benzoxazocines
ZA200608482B (en) Novel tetrahydropyridothiophenes
GB0505847D0 (en) Novel benzoxazocines
GB0408862D0 (en) Novel benzoxazocines
GB0328206D0 (en) Adjuvant
GB0420304D0 (en) Novel uses
GB0422614D0 (en) Novel uses
GB0420275D0 (en) Novel uses
GB0420279D0 (en) Novel uses
GB0420289D0 (en) Novel uses
GB0420301D0 (en) Novel uses
GB0420302D0 (en) Novel uses
GB0420262D0 (en) Novel uses
GB0420310D0 (en) Novel uses
GB0420312D0 (en) Novel uses

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)